2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons

Craig T. January, L. Samuel Wann, Hugh Calkins, Lin Y. Chen, Joaquin E. Cigarroa, Joseph C. Cleveland, Patrick T. Ellinor, Michael D. Ezekowitz, Michael E. Field, Karen L. Furie, Paul A. Heidenreich, Katherine T. Murray, Julie B. Shea, Cynthia M. Tracy, Clyde W. Yancy

Research output: Contribution to journalReview articlepeer-review

1851 Scopus citations
Original languageEnglish (US)
Pages (from-to)e125-e151
Issue number2
StatePublished - Jul 9 2019


  • AHA Scientific Statements
  • acute coronary syndrome
  • anticoagulants
  • anticoagulation agents
  • antiplatelet agents
  • apixaban
  • atrial fibrillation
  • atrial flutter
  • cardioversion
  • coronary artery disease
  • coronary heart disease
  • dabigatran
  • edoxaban
  • focused update
  • hypertension
  • idarucizumab
  • myocardial infarction
  • obesity
  • percutaneous coronary intervention
  • risk factors
  • rivaroxaban
  • sleep apnea
  • stents
  • stroke
  • thromboembolism
  • warfarin

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this